PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32330796-1 2020 Etoricoxib, a selective Cyclooxygenase-2 (COX-2) inhibitor, is commonly used in osteoarthritis (OA) for pain relief, however, little is known about the effects on subchondral bone. Etoricoxib 0-10 prostaglandin-endoperoxide synthase 2 Mus musculus 24-40 32330796-1 2020 Etoricoxib, a selective Cyclooxygenase-2 (COX-2) inhibitor, is commonly used in osteoarthritis (OA) for pain relief, however, little is known about the effects on subchondral bone. Etoricoxib 0-10 prostaglandin-endoperoxide synthase 2 Mus musculus 42-47 20609063-12 2010 CONCLUSIONS: The obtained results suggest that the preferential cyclooxygenase-2 inhibitor etoricoxib significantly reduced the anticonvulsant action of phenytoin and significantly increased the beneficial action of diazepam against maximal electroshock and pentylenetetrazole-induced convulsions in a mouse model. Etoricoxib 91-101 prostaglandin-endoperoxide synthase 2 Mus musculus 64-80 21441618-0 2011 Heme oxygenase/carbon monoxide-biliverdin pathway may be involved in the antinociceptive activity of etoricoxib, a selective COX-2 inhibitor. Etoricoxib 101-111 prostaglandin-endoperoxide synthase 2 Mus musculus 125-130